Global Bovine Rotavirus Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031.

Global Bovine Rotavirus Vaccine Market Size, Share and Analysis

The global Bovine Rotavirus Vaccine market size is predicted to grow from US$ million in 2025 to US$ million in 2031; it is expected to grow at a CAGR of %from 2025 to 2031. Bovine rotavirus is one of the main pathogens that cause viral diarrhea in calves. It has the characteristics of complex genotype, wide spread, high fatality rate, and interspecies transmission. Bovine rotavirus vaccine can effectively reduce viral diarrhea in calves. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs. Infinity Market Research newest research report, the Bovine Rotavirus Vaccine Industry Forecast looks at past sales and reviews total world Bovine Rotavirus Vaccine sales in 2024, providing a comprehensive analysis by region and market sector of projected Bovine Rotavirus Vaccine sales for 2025 through 2031. With Bovine Rotavirus Vaccine sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Bovine Rotavirus Vaccine industry. This Insight Report provides a comprehensive analysis of the global Bovine Rotavirus Vaccine landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Bovine Rotavirus Vaccine portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms unique position in an accelerating global Bovine Rotavirus Vaccine market. This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Bovine Rotavirus Vaccine and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Bovine Rotavirus Vaccine. This report presents a comprehensive overview, market shares, and growth opportunities of Bovine Rotavirus Vaccine market by product type, application, key manufacturers and key regions and countries. Segmentation by Type: &nbsp;&nbsp;&nbsp; Attenuated Vaccine &nbsp;&nbsp;&nbsp; Inactivated Vaccine Segmentation by Application: &nbsp;&nbsp;&nbsp; Calf &nbsp;&nbsp;&nbsp; Adult Cow This report also splits the market by region: &nbsp;&nbsp;&nbsp; Americas &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; United States &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Canada &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Mexico &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Brazil &nbsp;&nbsp;&nbsp; APAC &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; China &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Japan &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Korea &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Southeast Asia &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; India &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Australia &nbsp;&nbsp;&nbsp; Europe &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Germany &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; France &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; UK &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Italy &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Russia &nbsp;&nbsp;&nbsp; Middle East & Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Egypt &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; South Africa &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Israel &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; Turkey &nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; GCC Countries The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the companys coverage, product portfolio, its market penetration. &nbsp;&nbsp;&nbsp; Zoetis &nbsp;&nbsp;&nbsp; MSD Animal Health &nbsp;&nbsp;&nbsp; GSK &nbsp;&nbsp;&nbsp; Boehringer-Ingelheim &nbsp;&nbsp;&nbsp; Serum Institute of India &nbsp;&nbsp;&nbsp; Merck Animal Health &nbsp;&nbsp;&nbsp; Elanco Animal Health &nbsp;&nbsp;&nbsp; Pharmgal Bio &nbsp;&nbsp;&nbsp; Creative Biolabs &nbsp;&nbsp;&nbsp; Lanzhou Institute of Biological Products &nbsp;&nbsp;&nbsp; Weike Biotechnology Key Questions Addressed in this Report What is the 10-year outlook for the global Bovine Rotavirus Vaccine market? What factors are driving Bovine Rotavirus Vaccine market growth, globally and by region? Which technologies are poised for the fastest growth by market and region? How do Bovine Rotavirus Vaccine market opportunities vary by end market size? How does Bovine Rotavirus Vaccine break out by Type, by Application?

1 Scope of the Report &nbsp;1.1 Market Introduction &nbsp;1.2 Years Considered &nbsp;1.3 Research Objectives &nbsp;1.4 Market Research Methodology &nbsp;1.5 Research Process and Data Source &nbsp;1.6 Economic Indicators &nbsp;1.7 Currency Considered &nbsp;1.8 Market Estimation Caveats 2 Executive Summary &nbsp;2.1 World Market Overview &nbsp;2.1.1 Global Bovine Rotavirus Vaccine Annual Sales 2020-2031 &nbsp;2.1.2 World Current & Future Analysis for Bovine Rotavirus Vaccine by Geographic Region, 2020, 2024 & 2031 &nbsp;2.1.3 World Current & Future Analysis for Bovine Rotavirus Vaccine by Country/Region, 2020, 2024 & 2031 &nbsp;2.2 Bovine Rotavirus Vaccine Segment by Type &nbsp;2.2.1 Attenuated Vaccine &nbsp;2.2.2 Inactivated Vaccine &nbsp;2.3 Bovine Rotavirus Vaccine Sales by Type &nbsp;2.3.1 Global Bovine Rotavirus Vaccine Sales Market Share by Type (2020-2025) &nbsp;2.3.2 Global Bovine Rotavirus Vaccine Revenue and Market Share by Type (2020-2025) &nbsp;2.3.3 Global Bovine Rotavirus Vaccine Sale Price by Type (2020-2025) &nbsp;2.4 Bovine Rotavirus Vaccine Segment by Application &nbsp;2.4.1 Calf &nbsp;2.4.2 Adult Cow &nbsp;2.5 Bovine Rotavirus Vaccine Sales by Application &nbsp;2.5.1 Global Bovine Rotavirus Vaccine Sale Market Share by Application (2020-2025) &nbsp;2.5.2 Global Bovine Rotavirus Vaccine Revenue and Market Share by Application (2020-2025) &nbsp;2.5.3 Global Bovine Rotavirus Vaccine Sale Price by Application (2020-2025) 3 Global by Company &nbsp;3.1 Global Bovine Rotavirus Vaccine Breakdown Data by Company &nbsp;3.1.1 Global Bovine Rotavirus Vaccine Annual Sales by Company (2020-2025) &nbsp;3.1.2 Global Bovine Rotavirus Vaccine Sales Market Share by Company (2020-2025) &nbsp;3.2 Global Bovine Rotavirus Vaccine Annual Revenue by Company (2020-2025) &nbsp;3.2.1 Global Bovine Rotavirus Vaccine Revenue by Company (2020-2025) &nbsp;3.2.2 Global Bovine Rotavirus Vaccine Revenue Market Share by Company (2020-2025) &nbsp;3.3 Global Bovine Rotavirus Vaccine Sale Price by Company &nbsp;3.4 Key Manufacturers Bovine Rotavirus Vaccine Producing Area Distribution, Sales Area, Product Type &nbsp;3.4.1 Key Manufacturers Bovine Rotavirus Vaccine Product Location Distribution &nbsp;3.4.2 Players Bovine Rotavirus Vaccine Products Offered &nbsp;3.5 Market Concentration Rate Analysis &nbsp;3.5.1 Competition Landscape Analysis &nbsp;3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025) &nbsp;3.6 New Products and Potential Entrants &nbsp;3.7 Market M&A Activity & Strategy 4 World Historic Review for Bovine Rotavirus Vaccine by Geographic Region &nbsp;4.1 World Historic Bovine Rotavirus Vaccine Market Size by Geographic Region (2020-2025) &nbsp;4.1.1 Global Bovine Rotavirus Vaccine Annual Sales by Geographic Region (2020-2025) &nbsp;4.1.2 Global Bovine Rotavirus Vaccine Annual Revenue by Geographic Region (2020-2025) &nbsp;4.2 World Historic Bovine Rotavirus Vaccine Market Size by Country/Region (2020-2025) &nbsp;4.2.1 Global Bovine Rotavirus Vaccine Annual Sales by Country/Region (2020-2025) &nbsp;4.2.2 Global Bovine Rotavirus Vaccine Annual Revenue by Country/Region (2020-2025) &nbsp;4.3 Americas Bovine Rotavirus Vaccine Sales Growth &nbsp;4.4 APAC Bovine Rotavirus Vaccine Sales Growth &nbsp;4.5 Europe Bovine Rotavirus Vaccine Sales Growth &nbsp;4.6 Middle East & Africa Bovine Rotavirus Vaccine Sales Growth 5 Americas &nbsp;5.1 Americas Bovine Rotavirus Vaccine Sales by Country &nbsp;5.1.1 Americas Bovine Rotavirus Vaccine Sales by Country (2020-2025) &nbsp;5.1.2 Americas Bovine Rotavirus Vaccine Revenue by Country (2020-2025) &nbsp;5.2 Americas Bovine Rotavirus Vaccine Sales by Type (2020-2025) &nbsp;5.3 Americas Bovine Rotavirus Vaccine Sales by Application (2020-2025) &nbsp;5.4 United States &nbsp;5.5 Canada &nbsp;5.6 Mexico &nbsp;5.7 Brazil 6 APAC &nbsp;6.1 APAC Bovine Rotavirus Vaccine Sales by Region &nbsp;6.1.1 APAC Bovine Rotavirus Vaccine Sales by Region (2020-2025) &nbsp;6.1.2 APAC Bovine Rotavirus Vaccine Revenue by Region (2020-2025) &nbsp;6.2 APAC Bovine Rotavirus Vaccine Sales by Type (2020-2025) &nbsp;6.3 APAC Bovine Rotavirus Vaccine Sales by Application (2020-2025) &nbsp;6.4 China &nbsp;6.5 Japan &nbsp;6.6 South Korea &nbsp;6.7 Southeast Asia &nbsp;6.8 India &nbsp;6.9 Australia &nbsp;6.10 China Taiwan 7 Europe &nbsp;7.1 Europe Bovine Rotavirus Vaccine by Country &nbsp;7.1.1 Europe Bovine Rotavirus Vaccine Sales by Country (2020-2025) &nbsp;7.1.2 Europe Bovine Rotavirus Vaccine Revenue by Country (2020-2025) &nbsp;7.2 Europe Bovine Rotavirus Vaccine Sales by Type (2020-2025) &nbsp;7.3 Europe Bovine Rotavirus Vaccine Sales by Application (2020-2025) &nbsp;7.4 Germany &nbsp;7.5 France &nbsp;7.6 UK &nbsp;7.7 Italy &nbsp;7.8 Russia 8 Middle East & Africa &nbsp;8.1 Middle East & Africa Bovine Rotavirus Vaccine by Country &nbsp;8.1.1 Middle East & Africa Bovine Rotavirus Vaccine Sales by Country (2020-2025) &nbsp;8.1.2 Middle East & Africa Bovine Rotavirus Vaccine Revenue by Country (2020-2025) &nbsp;8.2 Middle East & Africa Bovine Rotavirus Vaccine Sales by Type (2020-2025) &nbsp;8.3 Middle East & Africa Bovine Rotavirus Vaccine Sales by Application (2020-2025) &nbsp;8.4 Egypt &nbsp;8.5 South Africa &nbsp;8.6 Israel &nbsp;8.7 Turkey &nbsp;8.8 GCC Countries 9 Market Drivers, Challenges and Trends &nbsp;9.1 Market Drivers & Growth Opportunities &nbsp;9.2 Market Challenges & Risks &nbsp;9.3 Industry Trends 10 Manufacturing Cost Structure Analysis &nbsp;10.1 Raw Material and Suppliers &nbsp;10.2 Manufacturing Cost Structure Analysis of Bovine Rotavirus Vaccine &nbsp;10.3 Manufacturing Process Analysis of Bovine Rotavirus Vaccine &nbsp;10.4 Industry Chain Structure of Bovine Rotavirus Vaccine 11 Marketing, Distributors and Customer &nbsp;11.1 Sales Channel &nbsp;11.1.1 Direct Channels &nbsp;11.1.2 Indirect Channels &nbsp;11.2 Bovine Rotavirus Vaccine Distributors &nbsp;11.3 Bovine Rotavirus Vaccine Customer 12 World Forecast Review for Bovine Rotavirus Vaccine by Geographic Region &nbsp;12.1 Global Bovine Rotavirus Vaccine Market Size Forecast by Region &nbsp;12.1.1 Global Bovine Rotavirus Vaccine Forecast by Region (2026-2031) &nbsp;12.1.2 Global Bovine Rotavirus Vaccine Annual Revenue Forecast by Region (2026-2031) &nbsp;12.2 Americas Forecast by Country (2026-2031) &nbsp;12.3 APAC Forecast by Region (2026-2031) &nbsp;12.4 Europe Forecast by Country (2026-2031) &nbsp;12.5 Middle East & Africa Forecast by Country (2026-2031) &nbsp;12.6 Global Bovine Rotavirus Vaccine Forecast by Type (2026-2031) &nbsp;12.7 Global Bovine Rotavirus Vaccine Forecast by Application (2026-2031) 13 Key Players Analysis &nbsp;13.1 Zoetis &nbsp;13.1.1 Zoetis Company Information &nbsp;13.1.2 Zoetis Bovine Rotavirus Vaccine Product Portfolios and Specifications &nbsp;13.1.3 Zoetis Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.1.4 Zoetis Main Business Overview &nbsp;13.1.5 Zoetis Latest Developments &nbsp;13.2 MSD Animal Health &nbsp;13.2.1 MSD Animal Health Company Information &nbsp;13.2.2 MSD Animal Health Bovine Rotavirus Vaccine Product Portfolios and Specifications &nbsp;13.2.3 MSD Animal Health Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.2.4 MSD Animal Health Main Business Overview &nbsp;13.2.5 MSD Animal Health Latest Developments &nbsp;13.3 GSK &nbsp;13.3.1 GSK Company Information &nbsp;13.3.2 GSK Bovine Rotavirus Vaccine Product Portfolios and Specifications &nbsp;13.3.3 GSK Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.3.4 GSK Main Business Overview &nbsp;13.3.5 GSK Latest Developments &nbsp;13.4 Boehringer-Ingelheim &nbsp;13.4.1 Boehringer-Ingelheim Company Information &nbsp;13.4.2 Boehringer-Ingelheim Bovine Rotavirus Vaccine Product Portfolios and Specifications &nbsp;13.4.3 Boehringer-Ingelheim Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.4.4 Boehringer-Ingelheim Main Business Overview &nbsp;13.4.5 Boehringer-Ingelheim Latest Developments &nbsp;13.5 Serum Institute of India &nbsp;13.5.1 Serum Institute of India Company Information &nbsp;13.5.2 Serum Institute of India Bovine Rotavirus Vaccine Product Portfolios and Specifications &nbsp;13.5.3 Serum Institute of India Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.5.4 Serum Institute of India Main Business Overview &nbsp;13.5.5 Serum Institute of India Latest Developments &nbsp;13.6 Merck Animal Health &nbsp;13.6.1 Merck Animal Health Company Information &nbsp;13.6.2 Merck Animal Health Bovine Rotavirus Vaccine Product Portfolios and Specifications &nbsp;13.6.3 Merck Animal Health Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.6.4 Merck Animal Health Main Business Overview &nbsp;13.6.5 Merck Animal Health Latest Developments &nbsp;13.7 Elanco Animal Health &nbsp;13.7.1 Elanco Animal Health Company Information &nbsp;13.7.2 Elanco Animal Health Bovine Rotavirus Vaccine Product Portfolios and Specifications &nbsp;13.7.3 Elanco Animal Health Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.7.4 Elanco Animal Health Main Business Overview &nbsp;13.7.5 Elanco Animal Health Latest Developments &nbsp;13.8 Pharmgal Bio &nbsp;13.8.1 Pharmgal Bio Company Information &nbsp;13.8.2 Pharmgal Bio Bovine Rotavirus Vaccine Product Portfolios and Specifications &nbsp;13.8.3 Pharmgal Bio Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.8.4 Pharmgal Bio Main Business Overview &nbsp;13.8.5 Pharmgal Bio Latest Developments &nbsp;13.9 Creative Biolabs &nbsp;13.9.1 Creative Biolabs Company Information &nbsp;13.9.2 Creative Biolabs Bovine Rotavirus Vaccine Product Portfolios and Specifications &nbsp;13.9.3 Creative Biolabs Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.9.4 Creative Biolabs Main Business Overview &nbsp;13.9.5 Creative Biolabs Latest Developments &nbsp;13.10 Lanzhou Institute of Biological Products &nbsp;13.10.1 Lanzhou Institute of Biological Products Company Information &nbsp;13.10.2 Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Product Portfolios and Specifications &nbsp;13.10.3 Lanzhou Institute of Biological Products Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.10.4 Lanzhou Institute of Biological Products Main Business Overview &nbsp;13.10.5 Lanzhou Institute of Biological Products Latest Developments &nbsp;13.11 Weike Biotechnology &nbsp;13.11.1 Weike Biotechnology Company Information &nbsp;13.11.2 Weike Biotechnology Bovine Rotavirus Vaccine Product Portfolios and Specifications &nbsp;13.11.3 Weike Biotechnology Bovine Rotavirus Vaccine Sales, Revenue, Price and Gross Margin (2020-2025) &nbsp;13.11.4 Weike Biotechnology Main Business Overview &nbsp;13.11.5 Weike Biotechnology Latest Developments 14 Research Findings and Conclusion

Report	Global Bovine Rotavirus Vaccine Market Growth, Trends and Opportunities 2025-31
Selected License	Multi ID: LPI50394

Buyer Information

Order Summary